Instituto Terapeutico Delta Ltda.

Could a bidding war for Brazil’s privately held Ache Laboratorios do for Latin America what Abbott Laboratories Inc. ’s gargantuan purchase of part of India’s Piramal Enterprises Ltd. did f

Financings In the fourth quarter of 2011, biopharma financings more than doubled to $2.7 billion from the previous quarter’s $1.4 billion, bringing total funding for 2011 to $14.1 billion. ( See Exhib

Could a bidding war for Brazil’s privately held Ache Laboratorios do for Latin America what Abbott Laboratories Inc. ’s gargantuan purchase of part of India’s Piramal Enterprises Ltd. did f

A look at financing, M&A, and alliance activity April–June 2010 In this issue, we present another installment of our quarterly review of pharmaceutical/biotechnology dealmaking – for the second quarte